Political Uproar in India After AstraZeneca Admits Blood Clot Side effect | Vantage with Palki Sharma
A political controversy has erupted in India after British pharma giant AstraZeneca admitted in a UK court that its Covid-19 vaccine leads to blood clots in "very rare cases". The company's statement came after 51 lawsuits accused the vaccine of being "defective" and leading to serious injury and death. AstraZeneca's admission led to questions over why the Indian government approved Covishield, which is the Indian version of the company's Covid-19 vaccine. Doctors have said that while the jab does carry minor risks of a blood clot, it far outweighs the health risks from Covid-19 infection. Palki Sharma breaks down this vaccine controversy.
---
AstraZeneca | Covid Vaccine | Rare Side Effect | Covishield | Firstpost | World News | News Live | Vantage | Palki Sharma | News
#covishield #astrazeneca #sideeffects #covid19 #vaccine #firstpost #vantageonfirstpost #palkisharma #worldnews
Vantage is a ground-breaking news, opinions, and current affairs show from Firstpost. Catering to a global audience, Vantage covers the biggest news stories from a 360-degree perspective, giving viewers a chance to assess the impact of world events through a uniquely Indian lens.
The show is anchored by Palki Sharma, Managing Editor, Firstpost.
By breaking stereotypes, Vantage aims to challenge conventional wisdom and present an alternative view on global affairs, defying the norm and opening the door to new perspectives. The show goes beyond the headlines to uncover the hidden stories – making Vantage a destination for thought-provoking ideas.
Vantage airs Monday to Friday at 9 PM IST on Firstpost across all leading platforms.
Subscribe to Firstpost channel and press the bell icon to get notified when we go live.
[ Ссылка ]
Follow Firstpost on Instagram:
[ Ссылка ]
Follow Firstpost on Facebook:
[ Ссылка ]
Follow Firstpost on Twitter:
[ Ссылка ]
Follow Firstpost on WhatsApp:
[ Ссылка ]
